- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stereotaxis Inc (STXS)
Stereotaxis Inc stock price live, this page displays NYSE STXS stock exchange data. View the STXS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Stereotaxis Inc real time stock price chart below.
What Is the Stereotaxis Inc Stock Price Today?
The Stereotaxis Inc stock price today is 2.760.
What Is the Stock Symbol for Stereotaxis Inc?
The stock symbol for Stereotaxis Inc is ""STXS.""
What Stock Exchange Does Stereotaxis Inc Trade On?
Stereotaxis Inc is listed and trades on the NYSE stock exchange.
Is Stereotaxis Inc a Good Stock to Buy?
Determining whether Stereotaxis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STXS quote. (ISIN: US85916J4094)
What Is the Stereotaxis Inc Stock Price Today?
The Stereotaxis Inc stock price today is 2.760.
What Is the Stock Symbol for Stereotaxis Inc?
The stock symbol for Stereotaxis Inc is ""STXS.""
What Stock Exchange Does Stereotaxis Inc Trade On?
Stereotaxis Inc is listed and trades on the NYSE stock exchange.
Is Stereotaxis Inc a Good Stock to Buy?
Determining whether Stereotaxis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STXS quote. (ISIN: US85916J4094)
NYSE
Currency in USD
Fair Value
An estimate of a Stereotaxis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.740
2.956
52 wk Range
1.540
3.051
STXS Scorecard
Full Analysis
Stock price movements are quite volatile
STXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Stereotaxis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7402.956
52 wk Range
1.5403.051
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STXS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Stereotaxis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
4.500
Upside
+63.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Stereotaxis Inc Company Profile
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Stereotaxis Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue of $8.8M, up 95% YoY, beating $7.75M forecast; EPS of -$0.05 surpassed -$0.07 estimate
- Stock closed down 2.67% at $2.19 after hours despite earnings beat; trading near Fair Value with beta of 1.51
- CE Mark approval for Genesis X robotic system and MAGIC ablation catheter positions company well in electrophysiology market
- Company expects double-digit revenue growth for 2025; system revenue $2-3M/quarter, recurring revenue aim of $7M in Q4
- CEO highlights pivotal year, focus on innovation strategy and upcoming launch of new technologies to accelerate growth
Last Updated: 08/08/2025, 11:04
Read Full TranscriptCompare STXS to Peers and Sector
Metrics to compare | STXS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTXSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.2x | −4.1x | −0.6x | |
PEG Ratio | 1.12 | −0.15 | 0.00 | |
Price/Book | 171.8x | 3.1x | 2.6x | |
Price / LTM Sales | 7.9x | 2.9x | 3.3x | |
Upside (Analyst Target) | 63.0% | 40.2% | 39.0% | |
Fair Value Upside | Unlock | 2.7% | 4.9% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.500
(+63.04% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-0.05 / -0.07
Revenue / Forecast
8.80M / 7.75M
People Also Watch
FAQ
What Stock Exchange Does Stereotaxis Trade On?
Stereotaxis is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Stereotaxis?
The stock symbol for Stereotaxis is "STXS."
What Is the Stereotaxis Market Cap?
As of today, Stereotaxis market cap is 250.20M.
What Is Stereotaxis's Earnings Per Share (TTM)?
The Stereotaxis EPS (TTM) is -0.28.
When Is the Next Stereotaxis Earnings Date?
Stereotaxis will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is STXS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Stereotaxis Stock Split?
Stereotaxis has split 2 times.
How Many Employees Does Stereotaxis Have?
Stereotaxis has 139 employees.
What is the current trading status of Stereotaxis (STXS)?
As of 26 Aug 2025, Stereotaxis (STXS) is trading at a price of 2.76, with a previous close of 2.76. The stock has fluctuated within a day range of 2.74 to 2.96, while its 52-week range spans from 1.54 to 3.05.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.